Ablysinol 99% ampule 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM40E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,014
Award facts
- Contract value 100% obligated
- $49,013.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 14, 2026, provides $49,013.89 in firm fixed-price funding through the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Ablysinol 99% Ampule 5ML pharmaceutical product. The contract is a non-set-aside award executed as a child delivery order under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $1 billion through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities.
The work will be performed at Amerisourcebergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. Amerisourcebergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor and healthcare solutions provider serving the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. The non-set-aside competitive award demonstrates the contractor's capability to meet federal procurement requirements and deliver essential pharmaceutical commodities to support military medical treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM40E?
SPE2DR26FM40E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FM40E worth?
The government has obligated $49,014 on SPE2DR26FM40E.
Is contract SPE2DR26FM40E an order under another contract?
Yes. SPE2DR26FM40E is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM40E competed?
The extent of competition for SPE2DR26FM40E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award